|
James D. Marks, M.D., Ph.D. is Director of the Medical-Surgical Intensive Care Unit, San Francisco General Hospital and Professor of Anesthesia and Pharmaceutical Chemistry at University of California, San Francisco. He holds a Ph.D. from the MRC Laboratory of Molecular Biology, Cambridge, UK on the making of human antibody fragments in bacteria and bacteriophage. His research interests include the development of phage display technology for production of human antibodies and the development of techniques for increasing antibody affinity. He has published more than 75 scientific papers and acts as a referee for top-ranking international journals including Nature Biotechnology, Nature Medicine, Journal of Molecular Biology, Gene, Blood, and Human Antibodies and Hybridomas. Dr. Marks is the co-inventor on 4 major phage display patents. | 